Waking the wimp redox-modulation activates human beta-defensin 1

Gut Microbes

Volumn 2, Issue 4, 2011, Pages

  Schroeder, Bjoern O ^a   Stange, Eduard F ^b   Wehkamp, Jan ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Antimicrobial peptides; Commensal bacteria; Disulphide bridges; Human beta defensin 1; Innate immunity; Intestinal microbiota; Mucosal host defence; Redox modulation; Thioredoxin

Indexed keywords

BETA DEFENSIN 1; DITHIOTHREITOL; PROTEINASE; THIOREDOXIN; TRYPSIN;

ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CANDIDA ALBICANS; DISULFIDE BOND; GRAM POSITIVE BACTERIUM; HUMAN; INTESTINE; MODULATION; MOUTH CAVITY; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION;

EID: 80054061296     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.2.4.17692     Document Type: Article

References (52)

1. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415:389-95.
2. Boman HG. Antibacterial peptides: basic facts and emerging concepts. J Intern Med 2003; 254:197-215.
3. Harder J, Glaser R, Schroder JM. Human antimicrobial proteins effectors of innate immunity. J Endotoxin Res 2007; 13:317-38.
4. Bevins CL. Antimicrobial peptides as effector molecules of mammalian host defense. Contrib Microbiol 2003; 10:106-48.
5. Martin E, Ganz T, Lehrer RI. Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol 1995; 58:128-36.
6. Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, et al. Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci USA 2002; 99:2129-33.
7. Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, et al. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 1985; 76:1427-35.
8. Bevins CL. Paneth cell defensins: key effector molecules of innate immunity. Biochem Soc Trans 2006; 34:263-6.
9. Bensch KW, Raida M, Magert HJ, Schulz KP, Forssmann WG. hBD-1: a novel beta-defensin from human plasma. FEBS Lett 1995; 368:331-5.
10. Wehkamp J, Schauber J, Stange EF. Defensins and cathelicidins in gastrointestinal infections. Curr Opin Gastroenterol 2007; 23:32-8.
11. Zhao C, Wang I, Lehrer RI. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996; 396:319-22.
12. Zucht HD, Grabowsky J, Schrader M, Liepke C, Jurgens M, Schulz KP, et al. Human beta-defensin-1: A urinary peptide present in variant molecular forms and its putative functional implication. Eur J Med Res 1998; 3:315-23.
13. Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, Conway BA, et al. Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci USA 1998; 95:14961-6.
14. Krisanaprakornkit S, Weinberg A, Perez CN, Dale BA. Expression of the peptide antibiotic human betadefensin 1 in cultured gingival epithelial cells and gingival tissue. Infect Immun 1998; 66:4222-8.
15. O'Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, et al. Expression and regulation of the human ß-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999; 163:6718-24.
16. Harder J, Meyer-Hoffert U, Wehkamp K, Schwichtenberg L, Schroder JM. Differential gene induction of human beta-defensins (hBD-1, -2, -3 and -4) in keratinocytes is inhibited by retinoic acid. J Invest Dermatol 2004; 123:522-9.
17. Tollin M, Bergman P, Svenberg T, Jornvall H, Gudmundsson GH, Agerberth B. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 2003; 24:523-30.
18. Nuding S, Zabel LT, Enders C, Porter E, Fellermann K, Wehkamp J, et al. Antibacterial activity of human defensins on anaerobic intestinal bacterial species: a major role of HBD-3. Microbes Infect 2009; 11:384-93.
19. Kocsis AK, Lakatos PL, Somogyvari F, Fuszek P, Papp J, Fischer S, et al. Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease. Scand J Gastroenterol 2008; 43:299-307.
20. Peyrin-Biroulet L, Beisner J, Wang G, Nuding S, Oommen ST, Kelly D, et al. Peroxisome proliferatoractivated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci USA 2010; 107:8772-7.
21. Dale BA, Fredericks LP. Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol 2005; 7:119-33.
22. Lehrer RI, Rosenman M, Harwig SS, Jackson R, Eisenhauer P. Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 1991; 137:167-73.
23. Wilson M. The GI Tract and its indigenous microbiota. 2005; 1:251-317.
24. Nagy E. Anaerobic infections: update on treatment considerations. Drugs 2010; 70:841-58.
25. Schroeder BO, Wu Z, Nuding S, Groscurth S, Marcinowski M, Beisner J, et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature 2011; 469:419-23.
26. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 1989; 264:13963-6.
27. Chae HZ, Chung SJ, Rhee SG. Thioredoxindependent peroxide reductase from yeast. J Biol Chem 1994; 269:27670-8.
28. Rubartelli A, Bajetto A, Allavena G, Wollman E, Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem 1992; 267:24161-4.
29. Angelini G, Gardella S, Ardy M, Ciriolo MR, Filomeni G, Di TG, et al. Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc Natl Acad Sci USA 2002; 99:1491-6.
30. Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, Lopez-Boado YS, Stratman JL, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999; 286:113-7.
31. Ghosh D, Porter E, Shen B, Lee SK, Wilk D, Drazba J, et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 2002; 3:583-90.
32. Mastroianni JR, Ouellette AJ. {alpha}-defensins in enteric innate immunity: Functional paneth cell {alpha}-defensins in mouse colonic lumen. J Biol Chem 2009.
33. Antalis TM, Shea-Donohue T, Vogel SN, Sears C, Fasano A. Mechanisms of disease: protease functions in intestinal mucosal pathobiology. Nat Clin Pract Gastroenterol Hepatol 2007; 4:393-402.
34. Molmenti EP, Perlmutter DH, Rubin DC. Cellspecific expression of alpha 1-antitrypsin in human intestinal epithelium. J Clin Invest 1993; 92:2022-34.
35. Meyer-Hoffert U, Wu Z, Kantyka T, Fischer J, Latendorf T, Hansmann B, et al. Isolation of SPINK6 in human skin: selective inhibitor of kallikreinrelated peptidases. J Biol Chem 2010; 285:32174-81.
36. Schmid M, Fellermann K, Fritz P, Wiedow O, Stange EF, Wehkamp J. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease. J Leukoc Biol 2007; DOI:10.1189/jlb.0906581.
37. Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, et al. Evolution of mammals and their gut microbes. Science 2008; 320:1647-51.
38. Mukherjee S, Vaishnava S, Hooper LV. Multi-layered regulation of intestinal antimicrobial defense. Cell Mol Life Sci 2008; 65:3019-27.
39. Bevins CL, Salzman NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 2011; 9:356-68.
40. Ryan LK, Dai J, Yin Z, Megjugorac N, Uhlhorn V, Yim S, et al. Modulation of human {beta}-defensin-1 (hBD-1) in plasmacytoid dendritic cells (PDC), monocytes and epithelial cells by influenza virus, Herpes simplex virus and Sendai virus and its possible role in innate immunity. J Leukoc Biol 2011.
41. Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA. Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol 2003; 41:90-6.
42. Ozturk A, Famili P, Vieira AR. The antimicrobial peptide DEFB1 is associated with caries. J Dent Res 2010; 89:631-6.
43. Feng Z, Jiang B, Chandra J, Ghannoum M, Nelson S, Weinberg A. Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J Dent Res 2005; 84:445-50.
44. Ouhara K, Komatsuzawa H, Yamada S, Shiba H, Fujiwara T, Ohara M, et al. Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells. J Antimicrob Chemother 2005; 55:888-96.
45. Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA 2005; 102:18129-34.
46. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003; 422:522-6.
47. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjoberg J, Amir E, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010; 11:76-83.
48. Masuda K, Sakai N, Nakamura K, Yoshioka S, Ayabe T. Bactericidal activity of mouse alpha-defensin cryptdin-4 predominantly affects noncommensal bacteria. J Innate Immun 2011; 3:315-26.
49. Ouellette AJ, Hsieh MM, Nosek MT, Cano GD, Huttner KM, Buick RN, et al. Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms. Infect Immun 1994; 62:5040-7.
50. Schlee M, Wehkamp J, Altenhoefer A, Oelschlaeger TA, Stange EF, Fellermann K. The Induction of Human Beta-Defensin-2 by the Probiotic Escherichia coli Nissle 1917 is Mediated through Flagellin. Infect Immun 2007; 75:2399-407.
51. Garcia JR, Krause A, Schulz S, Rodriguez-Jimenez FJ, Kluver E, Adermann K, et al. Human beta-defensin 4: a novel inducible peptide with a specific saltsensitive spectrum of antimicrobial activity. FASEB J 2001; 15:1819-21.
52. Yanagi S, Ashitani J, Ishimoto H, Date Y, Mukae H, Chino N, et al. Isolation of human beta-defensin-4 in lung tissue and its increase in lower respiratory tract infection. Respir Res 2005; 6:130.